Chief Financial Officer
Aurobindo Pharma Ltd · Healthcare · FY FY 2024-25
Santhanam Subramanian is the Chief Financial Officer of Aurobindo Pharma Ltd, an Indian healthcare company (as of FY 2024-25).
Santhanam Subramanian serves as the Chief Financial Officer, overseeing the financial health and strategic financial planning of Aurobindo Pharma Limited. He is instrumental in ensuring robust financial performance, compliance, and…
Total annual remuneration is in the ₹4–5 crore range for FY 2024-25. Based on remuneration disclosed in Aurobindo Pharma Ltd's annual report.
Available in the full dossier: exact total remuneration, the split across fixed pay, variable pay, perquisites and equity, year-on-year change, the pay-to-median employee ratio, KPI drivers, debt profile and board influence. See plans.
Santhanam Subramanian is the Chief Financial Officer of Aurobindo Pharma Ltd, an Indian healthcare company (as of FY 2024-25).
Aurobindo Pharma Ltd operates in the Healthcare sector.
Santhanam Subramanian's total annual remuneration is in the ₹4–5 crore range. The figure is based on remuneration disclosed in Aurobindo Pharma Ltd's annual report for FY 2024-25. The exact figure, the split across fixed pay, variable pay, perquisites and equity, the year-on-year change and the pay-to-median ratio are available in the full dossier on HeadhuntCFO.
Santhanam Subramanian's compensation, KPI drivers, debt profile and board influence are analysed from Aurobindo Pharma Ltd's annual report for FY 2024-25.
Search another company's CFO · CFO executive search · Pricing